GGrantIndex
Sort

65,743 grants matching single cell sequencing

A protease-deficient, low mutation rate E. coli for biotherapeutics production

$713,455
Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2014 · GM

Computational Methods for Genome Assembly, Transcript Assembly, and Gene Discovery

$713,435
Steven L. Salzberg · Johns Hopkins University · R01 · FY2021 · HG

Causes and consequences of differential APP processing in inhibitory and excitatory neurons

$713,402
Joanna L Jankowsky · Baylor College Of Medicine · R01 · FY2024 · AG

Genetic underpinnings of craniofacial disorders explored with spatial sequencing

$713,390
Hannele Ruohola-Baker · University Of Washington · R01 · FY2024 · DE

Accurate and unbiased single cell sequencing with digital droplet MDA

$713,363
Adam R. Abate · University Of California, San Francisco · R01 · FY2016 · HG

Role of inflammation, innate resistance, and immunity in carcinogenesis

$713,277
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies

$713,250
Ellis L Reinherz · Dana-Farber Cancer Inst · R01 · FY2022 · CA

Adipogenesis, triglyceride turnover and cellular composition of adipose tissue in response to endurance training (ATLAS)

$713,143
Lauren Marie Sparks · Adventhealth Orlando · R01 · FY2024 · DK

The role of RNA m6A modification in the regulation of HIV latency and reactivation

$713,048
Jonathan Karn · Case Western Reserve University · R33 · FY2025 · AI

Chromosomal microdeletions causing heart defects

$713,035
Janet C King · Children'S Hospital & Res Ctr At Oakland · R01 · FY2014 · HL

Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma

$713,011
Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2025 · CA

DNA Topoisomerases as Target of Action of Anticancer Drugs

$712,998
Yves Pommier · Basic Sciences · Z01 · FY2007 · CA

Ten-Fold Resolution Boost for Magnetic Particle Imaging with Applications to Rapid, Non-Invasive Imaging of CAR-T Cell Therapies, Stroke, GI Bleeds and Pulmonary Embolisms

$712,953
Steven M Conolly · University Of California Berkeley · U01 · FY2023 · EB

Integration of functional data and GWAS to elucidate genetic basis of diseases

$712,928
Jonathan K Pritchard · Stanford University · R01 · FY2023 · HG

An Autoimmune center of excellence for the study of IgG4-related disease

$712,878
Shiv Subramaniam Pillai · Massachusetts General Hospital · U19 · FY2014 · AI

NHGRI/DIR Genomics Core

$712,860
Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2014 · HG

Molecular Genetic Characterization of SCA8

$712,855
Laura Pw Ranum · University Of Florida · R37 · FY2019 · NS

Assessing the determinants of durable protective immunity in SARS-CoV-2 infected human subjects

$712,821
Stefan H.i. Kappe · Seattle Children'S Hospital · U01 · FY2021 · AI

Predicting context-specific molecular and phenotypic effects of genetic variation through the lens of the cis-regulatory code

$712,816
Anshul Kundaje · Stanford University · U01 · FY2025 · HG

Predicting context-specific molecular and phenotypic effects of genetic variation through the lens of the cis-regulatory code

$712,815
Anshul Kundaje · Stanford University · U01 · FY2024 · HG

Adaptive epigenetic mechanisms of beta and immune cells in autoimmune diabetes

$712,811
Kevan C Herold · Yale University · R01 · FY2021 · DK

Synergistic immune response after EphrinB2 inhibition & PD-1 antibody therapy in urothelial carcinoma.

$712,735
Sarmad Sadeghi · University Of Southern California · R01 · FY2025 · CA

Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases

$712,690
Bryan R. Cullen · Duke University · R01 · FY2016 · AI

CNS Viral Persistence and Neuropsychiatric Perturbations in HIV: Single cell and Molecular Interrogation

$712,643
Serena S Spudich · Yale University · R01 · FY2024 · MH

Next Generation Computational Tools for Functional Genomics

$712,621
Rafael Angel Irizarry · Dana-Farber Cancer Inst · R01 · FY2024 · HG